152 related articles for article (PubMed ID: 6309943)
1. Promutagen activation with mammalian and avian S9 liver microsomes.
Tometsko AM; Sheridan KM; DeTraglia MC
J Appl Toxicol; 1981 Feb; 1(1):11-4. PubMed ID: 6309943
[TBL] [Abstract][Full Text] [Related]
2. Promutagen activation by rodent-liver postmitochondrial fractions in the L5178Y/TK cell mutation assay.
Amacher DE; Turner GN
Mutat Res; 1980 Dec; 74(6):485-501. PubMed ID: 7464853
[TBL] [Abstract][Full Text] [Related]
3. Effects of the hepatic S9 fraction from aroclor-1254-treated rats on the mutagenicity of benzo[alpha]pyrene and 2-aminoanthracene in the Salmonella/microsome assay.
Zeiger E; Chhabra RS; Margolin BH
Mutat Res; 1979 Dec; 64(6):379-89. PubMed ID: 118381
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic activation of 2-aminoanthracene: implications in its use as diagnostic mutagen in the Ames test.
Ayrton AD; Neville S; Ioannides C
Mutat Res; 1992 Jan; 265(1):1-8. PubMed ID: 1370238
[TBL] [Abstract][Full Text] [Related]
5. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay.
Milling DM; Maddock MB
Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163
[TBL] [Abstract][Full Text] [Related]
6. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
Traynor CA; Shane BS; Hajos AK; Winston GW
Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
[TBL] [Abstract][Full Text] [Related]
7. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
Guobaitis RJ; Ellingham TJ; Maddock MB
Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
[TBL] [Abstract][Full Text] [Related]
8. Rat nasal tissue activation of benzo(a)pyrene and 2-aminoanthracene to mutagens in Salmonella typhimurium.
Bond JA; Li AP
Environ Mutagen; 1983; 5(3):311-8. PubMed ID: 6303770
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of methapyrilene for bacterial mutation with metabolic activation by Aroclor-induced, methapyrilene-induced and noninduced rat-liver S9.
Oberly TJ; Scheuring JC; Richardson KA; Richardson FC; Garriott ML
Mutat Res; 1993 Apr; 299(2):77-84. PubMed ID: 7680426
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-mediated mutagenicity of mononitrobenzo[a]pyrenes in Salmonella typhimurium strains.
Hass BS; Heflich RH; Chou MW; White GL; Fu PP; Casciano DA
Mutat Res; 1986; 171(2-3):123-9. PubMed ID: 3528834
[TBL] [Abstract][Full Text] [Related]
11. Effect of induction by DDT on metabolism and mutagenicity of benzo[a]pyrene.
Bonin AM; Stupans I; Baker RS; Ryan AJ; Holder GM
Mutat Res; 1985 Dec; 158(3):111-7. PubMed ID: 3908923
[TBL] [Abstract][Full Text] [Related]
12. Activation of the food mutagens IQ and MeIQ by hepatic S9 fractions derived from various species.
Alldrick AJ; Rowland IR
Mutat Res; 1985 Oct; 144(2):59-62. PubMed ID: 3900706
[TBL] [Abstract][Full Text] [Related]
13. Effect of dietary casein levels on activation of promutagens in the spiral Salmonella mutagenicity assay. II. Studies with induced rat liver S9.
Woodall GM; Dauterman WC; DeMarini DM
Mutat Res; 1996 Jun; 360(2):127-43. PubMed ID: 8649465
[TBL] [Abstract][Full Text] [Related]
14. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
[TBL] [Abstract][Full Text] [Related]
15. Potential pitfalls associated with testing of enzyme preparations in the Salmonella/microsome assay.
Conti L; Crebelli R
Regul Toxicol Pharmacol; 2016 Oct; 80():291-4. PubMed ID: 27330008
[TBL] [Abstract][Full Text] [Related]
16. A comparison of avian and rodent S-9 liver homogenates in the Ames test.
Rosanoff KA; Jones DH; Sawyer TW
Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):131-9. PubMed ID: 6328598
[TBL] [Abstract][Full Text] [Related]
17. Test-condition-dependent influence of harman and nonharman on benzo[a]pyrene mutagenesis in Salmonella.
Riebe M; Westphal K; Keller H
Mutat Res; 1982 Apr; 104(1-3):9-15. PubMed ID: 7043258
[TBL] [Abstract][Full Text] [Related]
18. Comparative mutagenicity tests in the Salmonella/microsome assay with rat and woodchuck S9 preparations.
Rashid KA; Babish JG; Johnson BE; Mumma RO
Toxicology; 1985 Aug; 36(2-3):139-46. PubMed ID: 3931301
[TBL] [Abstract][Full Text] [Related]
19. Mutagenic activity of biliary metabolites of 6-hydroxymethylbenzo[a]pyrene.
Hughes MF; Kadry AR; Gairola CG; Flesher JW
Mutat Res; 1986 Apr; 173(4):251-6. PubMed ID: 3513004
[TBL] [Abstract][Full Text] [Related]
20. Induction of the hepatic mixed-function oxidases by Aroclor 1254 in the hamster: comparison of Aroclor-induced rat and hamster preparations in the activation of pre-carcinogens in the Ames test.
Hyde R; Smith JN; Ioannides C
Mutagenesis; 1987 Nov; 2(6):477-82. PubMed ID: 3127658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
